Onsite Tobacco Cessation Treatment for Patients With PAD

Status unconfirmed · Not applicable

Conditions studied: Tobacco Cessation, Peripheral Artery Disease

In brief

Tobacco cessation treatment is needed for individuals with peripheral artery disease (PAD) to improve symptoms, lower cardiovascular risk, and prevent amputation. While such treatment is effective, many PAD patients do not receive cessation therapy. Participants will receive nicotine replacement therapy, counseling, and and complete questionnaires. We hypothesize that integrating tobacco cessation services into a dedicated PAD clinic (OU CVI Limb Preservation Clinic) can improve tobacco cessation rates and improve PAD-related health outcomes in this at risk population.

Key facts

Study ID

NCT05469698

Run by

University of Oklahoma

People needed

15

Starts

2022-08-16

Expected to finish

2024-07-31

Last updated by the study team

2024-02-15

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Have diagnosed peripheral artery disease
• Tobacco user
• 18 years of age or older
• Willing/able to attend all study visits
• Be able to read, speak, and understand English

You may not qualify if…

• Do not meet the specified inclusion criteria above

Where it is running

• TSET Health Promotion Research Center — Oklahoma City, Oklahoma, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.